Evidence map›Paper›PMID 20961644›Full record

ArticleJournal of hepatology2011

Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease.

Zoltan Derdak, Charles H Lang, Kristine A Villegas, Ming Tong, Nicholas M Mark, Suzanne M de la Monte, Jack R Wands

Abstract readComparative Study
In one paragraph

Article in Journal of hepatology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Protective Effects ofInternational journal of molecular sciences · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. The role of TIGAR in nervous system diseases.Frontiers in aging neuroscience · 2022
    Review
  19. Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Zoltan DerdakDivision of Gastroenterology and Liver Research Center, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI 02903, USA. Zoltan_Derdak@brown.edu
Charles H Lang
Kristine A Villegas
Ming Tong
Nicholas M Mark
Suzanne M de la Monte
Jack R Wands
Rhode Island Hospital · USBrown University · USPennsylvania State University · US

Funding

FASD Inhibition of ASPH-Notch Mediates Adolescent Cerebral White Matter Pathology-Potential Utility of Non-invasive Extracellular Vesicle AssaysR01AA011431 · NIAAA · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI SUZANNE M. DE LA MONTE · 1996 to 2026
$5.4M
STUDY OF HBV AND/OR VARIANTS IN ALCOHOLICSR01AA008169 · NIAAA · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI WANDS, JACK R · 1989 to 2011
$3.9M
Ethanol, IRS-1 Signaling and Neuronal MigrationR37AA011431 · NIAAA · RHODE ISLAND HOSPITAL · PI DE LA MONTE, SUZANNE M. · 2009 to 2018
$3.7M
Regulation of Nutrient Sensing and Muscle Wasting by AlcoholR01AA011290 · NIAAA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI LANG, CHARLES H. · 1997 to 2011
$3.5M
Regulation of Nutrient Sensing and Muscle Wasting by AlcoholR37AA011290 · NIAAA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI LANG, CHARLES H. · 2012 to 2021
$3.4M
EFFECTS OF ETHANOL ON INSULIN SIGNALING IN THE BRAINR01AA012908 · NIAAA · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI DE LA MONTE, SUZANNE M. · 2003 to 2013
$3.0M
EFFECTS OF ALCOHOL ON THE LIVERR01AA002666 · NIAAA · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI WANDS, JACK R · 1985 to 2007
$2.6M
ETHANOL, INSULIN/IGF SIGNALING AND NEURONAL MIGRATIONR56AA011431 · NIAAA · RHODE ISLAND HOSPITAL · PI DE LA MONTE, SUZANNE M. · 2008 to 2008
$312k
EFFECTS OF ALCOHOL ON THE LIVERR37AA002666 · NIAAA · MASSACHUSETTS GENERAL HOSPITAL · PI WANDS, JACK R · 1989 to 1997
–
NIAAA NIH HHS AA002666NIAAA NIH HHS AA008169NIAAA NIH HHS AA011431NIAAA NIH HHS AA012908NIAAA NIH HHS AA11290NIAAA NIH HHS R01 AA002666NIAAA NIH HHS R01 AA008169NIAAA NIH HHS R01 AA011290NIAAA NIH HHS R01 AA011431NIAAA NIH HHS R01 AA012908NIAAA NIH HHS R37 AA002666NIAAA NIH HHS R37 AA011290NIAAA NIH HHS R37 AA011431NIAAA NIH HHS R56 AA011431
6 · The paper itself

Abstract

BACKGROUND &

aimsChronic ethanol consumption in the Long-Evans (LE) rat has been associated with hepatic p53 activation, and inhibition of the insulin/PI3K/AKT signal transduction cascade due to increased expression of PTEN. We hypothesize that p53 activation and altered insulin signaling may influence the susceptibility of rats to ethanol-induced liver damage. Furthermore, p53 not only activates programmed cell death pathways and suppresses hepatocellular survival signals, but also promotes gluconeogenesis to increase systemic insulin resistance due to a novel metabolic function.

methodsFischer (F), Sprague-Dawley (SD) and LE rats were fed ethanol-containing or control liquid diet for 8 weeks. Histopathological and biochemical changes were assessed.

resultsHere, we demonstrate that chronic ethanol feeding in rats promotes p53 activation, hepatic steatosis, oxidative stress, PUMA, and PTEN expression, which contribute to hepatocellular death and diminished insulin signaling in the liver. Such changes are pronounced in the LE, less prominent in SD, and virtually absent in the F rat strain. More importantly, there is activation of Tp53-induced glycolysis and apoptosis regulator (TIGAR) in the ethanol-fed LE rat. This event generates low hepatic fructose-2,6-bisphosphate (Fru-2,6-P₂) levels, reduced lactate/pyruvate ratio and may contribute to increased basal glucose turnover and high residual hepatic glucose production during euglycemic hyperinsulinemic clamp.

conclusionsp53 activation correlates with the susceptibility to ethanol-induced liver damage in different rat strains. p53 not only orchestrates apoptosis and suppresses cell survival, but by activating TIGAR and decreasing hepatic Fru-2,6-P₂) levels it promotes insulin resistance and therefore, contributes to the metabolic abnormalities associated with hepatic steatosis.

Indexed as

Alanine TransaminaseAnimalsApoptosisApoptosis Regulatory ProteinsCaspase 3Disease Models, AnimalDNA DamageDNA, MitochondrialFatty Liver, AlcoholicFructosediphosphatesGluconeogenesisInsulin ResistanceLiver Diseases, AlcoholicMaleOxidative StressPoly(ADP-ribose) PolymerasesAlanine TransaminaseApoptosis Regulatory ProteinsBbc3 protein, ratCasp3 protein, ratCaspase 3DNA, Mitochondrialfructose 2,6-diphosphateFructosediphosphatesPoly(ADP-ribose) PolymerasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePten protein, ratSrebf1 protein, ratSterol Regulatory Element Binding Protein 1Tumor Suppressor Protein p53

Identifiers

PMID20961644
PMCPMC2994971
OpenAlexW1977247288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.